Sign in
Taking people in United StatesNo phase

Diets and weight change to study how obesity leads to insulin resistance

Studies how weight change and diets affect insulin resistance.

Key facts

Who runs it
Stanford University
Where
Stanford, United StatesSee the site
Trial code
Registry title
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
Status
Recruiting
People taking part
110 people, planned
Started
31 Jan 2019
Expected to end
30 Dec 2026
Type of study
Interventional, 3 groups
Treatments tested
  • Dietary Intervention Mediterranean Low Carbohydrate Diet
  • Dietary Intervention Standard Low Carbohydrate Diet
  • Dietary Intervention Standard Low Fat Diet
Record updated
4 December 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 35 to 65 with a BMI of 25-35 kg/m2, stable weight and no diabetes, for a 12-week diet and weight study.

Age
35 to 65 years
Sex
All sexes can join.
Disease stage
No diabetes. BMI of 25-35 kg/m2.
Earlier treatment
People cannot have used weight loss medication, statins or oral steroids.

Main reasons for not taking part

  • Diabetes, or fasting glucose of 126 mg/dL (7 mmol/L) or more
  • Major organ disease
  • History of liposuction or bariatric surgery
  • Active eating or psychiatric disorder
  • Pregnancy or lactation, heavy alcohol use

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • Age 35-65
  • BMI 25-35 kg/m2
  • Stable body weight
  • Nondiabetic

Who cannot take part

  • use of weight loss medication, statins, or oral steroids; Clinical screening exclusions
  • diabetes
  • major organ disease
  • history of liposuction or bariatric surgery
  • active eating or psychiatric disorder
  • fasting glucose >/= 126 mg/dL
  • Patients with
  • pregnancy or lactation, heavy alcohol use
  • recent change in weight (over the past 12 weeks)
  • hematocrit < 33%
  • blood pressure >160/100 mmHg

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 35 and 65 years old?

Where in United States

  • Stanford UniversityStanford, United StatesContact: Ekrem M Ayhan, BSTaking people

About the trial

What the trial wants to find out

This 12-week controlled diet and weight intervention study seeks to define the molecular pathways that link excess body weight to the development of insulin resistance (IR). Blood, adipose and stool are sampled at three timepoints; baseline, peak weight (4 weeks) and post weight loss to monitor changes in cellular processes. Additionally, direct insulin sensitivity testing, and radiological measurement of visceral fat and intrahepatic fat content is measured at three timepoints to correlate clinical indices with cellular changes.

The 3 groups in the trial

  • Mediterranean Low Carbohydrate DietTreatment being tested

    Assigned participants will receive instruction by a registered dietitian on a diet that is high in unsaturated fats and low in carbohydrates. Total caloric intake will be adjusted to induce a supervised metabolic challenge defined as weight gain of approximately 2.5 kg over 5 weeks followed by 3-5kg weight loss over 8 weeks.

    Treatment: Dietary Intervention Mediterranean Low Carbohydrate Diet

  • Standard Low Carbohydrate DietTreatment being tested

    Assigned participants will receive instruction by a registered dietitian on a low carbohydrate diet that is high in fats found in the typical American diet. Total caloric intake will be adjusted to induce a supervised metabolic challenge defined as weight gain of approximately 2.5 kg over 5 weeks followed by 3-5kg weight loss over 8 weeks.

    Treatment: Dietary Intervention Standard Low Carbohydrate Diet

  • Low Fat, Healthy Carbohydrate DietTreatment being tested

    Assigned participants will receive instruction by a registered dietitian on a low fat diet that is high in complex carbohydrates. Total caloric intake will be adjusted to induce a supervised metabolic challenge defined as weight gain of approximately 2.5 kg over 5 weeks followed by 3-5kg weight loss over 8 weeks.

    Treatment: Dietary Intervention Standard Low Fat Diet

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
Plain-language title
Diets and weight change to study how obesity leads to insulin resistanceGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT05165706, who can take part
Record updated
4 December 2024